PDF(1022 KB)
儿童恶性肿瘤相关性噬血细胞综合征24例临床分析
张婉妍, 张园, 董南南, 王颖超, 盛光耀, 徐学聚, 刘玉峰
中国当代儿科杂志 ›› 2018, Vol. 20 ›› Issue (4) : 295-297.
PDF(1022 KB)
PDF(1022 KB)
儿童恶性肿瘤相关性噬血细胞综合征24例临床分析
Clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis in children: a clinical analysis of 24 cases
目的 探讨儿童恶性肿瘤相关性噬血细胞综合征（MAHS）的临床特征和预后。方法 针对24例MAHS的原发病、临床特点与转归进行回顾性分析。结果 24例患儿中11例（46%）为肿瘤诱发，13例（54%）为化疗相关。原发病为急性白血病的有17例、淋巴瘤6例、神经母细胞瘤1例。临床表现以发热、呼吸系统症状、肝脾肿大为前三位常见症状。血细胞减少、血清铁蛋白升高、乳酸脱氢酶水平升高为前三位常见的实验室异常。22例给予HLH-2004方案治疗、2例放弃治疗。24例中死亡18例、失访1例、存活5例，生存时间3 d至2年4个月不等，中位生存期28 d。结论 儿童恶性肿瘤相关性噬血细胞综合征临床表现多样，治疗效果极差。
Objective To investigate the clinical features and prognosis of malignancy-associated hemophagocytic lymphohistiocytosis (MAHS) in children. Methods A retrospective analysis was performed for the primary diseases, clinical features, and prognosis of 24 children with MAHS. Results Among the 24 children, 11 (46%) had MAHS induced by tumor and 13 (54%) had chemotherapy-associated MAHS. As for primary diseases, 17 children had acute leukemia, 6 had lymphoma, and 1 had neuroblastoma. The most common clinical manifestations were pyrexia, respiratory symptoms, and hepatosplenomegaly. The most common laboratory abnormalities were hemocytopenia, elevated serum ferritin, and elevated lactate dehydrogenase. Of the 24 children, 22 were treated according to the HLH-2004 protocol and 2 gave up treatment; 18 children died, 1 was lost to follow-up, and 5 survived. The survival time ranged from 3 days to 2 years and 4 months (median 28 days). Conclusions Children with MAHS have various clinical features and extremely poor treatment outcomes.
恶性肿瘤相关性噬血细胞综合征 / 急性白血病 / 淋巴瘤 / 儿童
Malignancy-associated hemophagocytic lymphohistiocytosis / Acute leukemia / Lymphoma / Child
[1] Brisse E, Wouters CH, Matthys P. Hemophagocytic lymphohistiocytosis (HLH):A heterogeneous spectrum of cytokine-driven immune disorders[J]. Cytokine Growth Factor Rev, 2015, 26(3):263-280.
[2] Lehmberg K, Sprekels B, Nichols KE, et al. Malignancy-associated haemophagocytic lymphohistiocytosis in children and adolescents[J]. Br J Haematol, 2015, 170(4):539-549.
[3] Henter JI, Horne AC, Aricó M, et al. HLH-2004:Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis[J]. Pediatr Blood Cancer, 2007, 48(2):124-131.
[4] 中华医学会儿科学分会血液学组《中华儿科杂志》编辑委员会. 儿童急性淋巴细胞白血病诊疗建议(第四次修订)[J].中华儿科杂志, 2014, 52(9):641-644.
[5] 中华医学会儿科学分会血液学组《中华儿科杂志》编辑委员会. 儿童急性髓细胞白血病诊疗建议[J]. 中华儿科杂志, 2006, 44(11):877-878.
[6] Ramos-Casals M, Brito-Zeron P, Lopez-Guillermo A, et al. Adult haemophagocytic symdrome[J]. Lancet, 2014, 383(9927):1503-1516.
[7] Lehmberg K, Nichols KE, Henter JI, et al. Consensus recommendations for the diagnosis and management of hemophagocytic lymphohistiocytosis associated with malignancies[J]. Haematologica, 2015, 100(8):997-1004.
[8] 王滕滕, 袁田, 张翼骛. EB病毒与其相关淋巴瘤的研究进展[J]. 中国实验血液学杂志, 2014, 22(6):1775-1779.
[9] Chia J, Yeo KP, Whisstock JC, et al. Temperature sensitivity of human perforin mutants unmasks subtotal loss of cytotoxicity, delayed FHL, and a predisposition to cancer[J]. Proc Natl Acad Sci U S A, 2009, 106(24):9809-9814.
[10] Clementi R, Locatelli F, Dupré L, et al. A proportion of patients with lymphoma may harbor mutations of the perforin gene[J]. Blood, 2005, 105(11):4424-4428.
[11] Marsh RA, Madden L, Kitchen BJ. XIAP deficiency:a unique primary immunodeficiency best classified as X-linked familial hemophagocytic lymphohistiocytosis and not as X-linked lymphoproliferative disease[J]. Blood, 2010, 116(7):1079-1082.
[12] 周玉兰, 张荣艳, 李菲. 恶性肿瘤相关噬血细胞综合征的研究新进展[J]. 中国肿瘤临床, 2016, 43(21):958-961.
